Passive immunization of mice with IgY anti-H5N1 protects against experimental influenza virus infection and allows development of protective immunity
Author:
Eriksson MalinORCID,
Nylén SusanneORCID,
Grönvik Kjell-Olov
Reference72 articles.
1. Jin X, Ren J, Li R, Gao Y, Zhang H, Li J, et al. Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019. eClinicalMedicine. 2021;37.
2. A randomized, controlled trial of Ebola virus disease therapeutics;Mulangu;N Engl J Med,2019
3. Slifka MK, Amanna IJ. 8 - Passive Immunization. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM, editors. Plotkin's Vaccines (Seventh Edition): Elsevier; 2018. p. 84-95.e10.
4. Monoclonal antibodies as anti-infective products: a promising future?;Pelfrene;Clin Microbiol Infect,2019
5. The Antibody Society. Therapeutic monoclonal antibodies approved or in review in the EU or US.